Alzheimer’s disease (AD) and vascular dementia (VaD) lead to progressive decline in executive function. We estimated the prevalence of executive dysfunction in AD and VaD patients, investigating cognitive, functional, and clinical correlates and also using a multidimensional approach based on a standardized comprehensive geriatric assessment (CGA). We included 215 patients (115 AD patients and 100 VaD patients) consecutively evaluated with a complete cognitive and affective assessment, a CGA, and the Frontal Assessment Battery (FAB) with six subtests investigating conceptualization, mental flexibility, motor programming, sensitivity to interference, inhibitory control, and environmental autonomy. The prevalence of dysexecutive syndrome screened with a FAB score <12 points was high in both AD (97 patients) and VaD (77 patients) (84.3% versus 77.0%, p = 0.171). AD patients were significantly younger, with higher grade of cognitive impairment and less severe comorbidity and polypharmacy than VaD patients. AD patients showed a significantly higher impairment in FAB total score and five FAB subtests (conceptualization, motor programming, sensitivity to interference, inhibitory control, and environmental autonomy) than VaD patients. These findings were largely confirmed in a sub-analysis conducted subdividing the sample in mild and moderate-to-severe demented patients and suggesting that in moderate-to-severe AD there was higher impairment in FAB total score and four FAB subtests (conceptualization, sensitivity to interference, inhibitory control, and environmental autonomy). Executive dysfunction could be greater in AD patients with moderate-to-severe dementia compared to VaD patients, although our groups were also not matched for age, comorbidity or polypharmacy, which could also exert an effect.
DencklaMB (1994) Management of executive functioning. In: Frames of Reference for the Assessment of Learning Disabilities: New Views on Measurement Issues,
PaulH, ed. Lyon GR’s, Baltimore, pp. 117–142.
2.
McPhersonEG, SimpsonJR (2002) A comparison of municipal forest benefits and costs in Modesto and Santa Monica, California, USA. Urban For Urban Green1, 61–74.
3.
SjöbeckM, ElfgrenC, LarssonEM, BrockstedtS, LättJ, EnglundE, PassantU (2010) Alzheimer’s disease (AD) and executive dysfunction. A case-control study on the significance of frontal white matter changes detected by diffusion tensor imaging (DTI). Arch Gerontol Geriatr50, 260–266.
4.
BoylePA, Cahn-WeinerD (2005) Assessment and prediction of functional impairment in vascular dementia. Expert Rev Neurother4, 109–114.
5.
RocaM, ParrA, ThompsonR, WoolgarA, TorralvaT, AntounN, ManesF, DuncanJ (2010) Executive function and fluid intelligence after frontal lobe lesions. Brain133, 234–247.
6.
SchroeterML, VogtB, FrischS, BeckerG, BarthelH, MuellerK, VillringerA, SabriO (2012) Executive deficits are related to the inferior frontal junction in early dementia. Brain135, 201–205.
7.
StokholmJ, VogelA, GadeA, WaldemarG (2006) Heterogeneity in executive impairment in patients with very mild Alzheimer’s disease. Dement Geriatr Cogn Disord22, 54–59.
8.
JohnsonJK, LuiLY, YaffeK (2007) Executive function, more than global cognition, predicts functional decline and mortality in elderly women. J Gerontol A Biol Sci Med Sci62, 1134–1141.
9.
KoppelJ, GoldbergTE, GordonML, HueyE, DaviesP, KeehlisenL, HuetS, ChristenE, GreenwaldBS (2012) Relationships between behavioral syndromes and cognitive domains in Alzheimer disease: The impact of mood and psychosis. Am J Geriatr Psychiatry20, 994–1000.
10.
American Psychiatric Association (2013), Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC.
11.
McKhannGM, KnopmanDS, ChertkowH, HymanBT, JackCRJr, KawasCH, KlunkWE, KoroshetzWJ, ManlyJJ, MayeuxR, MohsRC, MorrisJC, RossorMN, ScheltensP, CarrilloMC, ThiesB, WeintraubS, PhelpsCH (2011) The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 263–269.
12.
BudsonAE, PriceBH (2005) Memory dysfunction. N Engl J Med352, 692–699.
13.
MartyrA, ClareL (2012) Executive function and activities of daily living in Alzheimer’s disease: A correlational meta-analysis. Dement Geriatr Cogn Disord33, 189–203.
14.
RoyallDR, LauterbachEC, KauferD, MalloyP, CoburnKL, BlackKJ, Committee on Research of the American Neuropsychiatric Association (2007) The cognitive correlates of functional status: A review from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci19, 249–265.
15.
SalmonDP, BondiMW (2009) Neuropsychological assessment of dementia. Annu Rev Psychol60, 257–282.
DuboisB, SlachevskyA, LitvanI, PillonB (2000) The FAB: A frontal assessment battery at bedside. Neurology55, 1621–1626.
18.
ApollonioI, LeoneM, IsellaV, PiamartaF, ConsoliT, VillaML, ForapaniE, RussoA, NichelliP (2005) The frontal assessment battery (FAB): Normative values in an Italian population sample. Neurol Sci26, 108–116.
19.
OguroH, YamaguchiS, AbeS, IshidaY, BokuraH, KobayashiS. (2006) Differentiating Alzheimer’s disease from subcortical vascular dementia with the FAB test. J Neurol253, 1490–1494.
20.
MokVC, WongA, YimP, FuM, LamWW, HuiAC, YauC, WongKS (2004) The validity and reliability of Chinese frontal assessment battery in evaluating executive dysfunction among Chinese patients with small subcortical infarct. Alzheimer Dis Assoc Disord18, 68–74.
21.
FukuiT, LeeE, KitamuraM, HosodaH, BokuiC, IkusuK, OkitaK (2009) Visuospatial dysfunction may be a key in the differentiation between Alzheimer’s disease and subcortical cognitive impairment in moderate to severe stages. Dement Geriatr Cogn Disord28, 288–294.
22.
BobanM, MalojcićB, MimicaN, VukovićS, ZrilićI (2012) The Frontal Assessment Battery in the differential diagnosis of dementia. J Geriatr Psychiatry Neurol25, 201–207.
23.
D’OnofrioG, PanzaF, SancarloD, ParisFF, CascavillaL, MangiacottiA, LauriolaM, ParoniGH, SeripaD, GrecoA (2016) Delusions in patients with Alzheimer’s disease: A multidimensional approach. J Alzheimers Dis51, 427–437.
24.
PilottoA, CellaA, PilottoA, DaragjatiJ, VeroneseN, MusacchioC, MelloAM, LogroscinoG, PadovaniA, PreteC, PanzaF (2017) Three decades of comprehensive geriatric assessment: Evidence coming from different healthcare settings and specific clinical conditions. J Am Med Dir Assoc18, 192.e1–192.e11.
25.
D’OnofrioG, SancarloD, AddanteF, CicconeF, CascavillaL, ParisF, EliaAC, NuzzaciC, PicocoM, GrecoA, PanzaF, PilottoA (2015) A pilot randomized controlled trial evaluating an integrated treatment of rivastigmine transdermal patch and cognitive stimulation in patients with Alzheimer’s disease. Int J Geriatr Psychiatry30, 965–975.
26.
FolsteinM, FolsteinS, McHughPR (1975) Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res12, 189–198.
27.
RouleauI, SalmonDP, ButtersN, KennedyC, McGuireK (1992) Quantitative and qualitative analyses of clock drawings in Alzheimer’s and Huntington’s disease. Brain Cogn18, 70–87.
28.
HughesCP, BergL, DanzigerWL, CobenLA, MartinRL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry140, 566–572.
29.
MorrisJC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology43, 2412–2414.
30.
D’AthP, KatonaP, MullanE, EvansS, KatonaC (1994) Screening, detection and management of depression in elderly primary care attenders. I: The acceptability and performance of the 15 item Geriatric Depression Scale (GDS-15) and the development of short versions. Fam Pract11, 260–266.
31.
American Psychiatric Association (2000), Diagnostic and statistical manual of mental disorders (4th ed., text rev). Washington, DC.
32.
RomanGC, TatemichiTK, ErkinjunttiT, CummingsJL, MasdeuJC, GarciaJH, AmaducciL, OrgogozoJM, BrunA, HofmanA, MoodyDM, O’BrienMD, YamaguchiT, GrafmanJ, DrayerBP, BennettDA, FisherM, OgataJ, KokmenE, BermejoF, WolfPA, GorelickPB, BickKL, PajeauAK, BellMA, DeCarliC, CulebrasA, KorczynAD, BogousslavskyJ, HartmannA, ScheinbergP (1993) Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology43, 250–260.
HachinskiVC, IliffLD, ZilhkaE, Du BoulayGH, McAllisterVL, MarshallJ, RussellRW, SymonL (1975) Cerebral blood flow in dementia. Arch Neurol32, 632–637.
35.
KatzS, DownsTD, CashHR, GrotzRC (1970) Progress in the development of an index of ADL. Gerontologist10, 20–30.
36.
LawtonMP, BrodyEM (1969) Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist9, 179–186.
37.
PfeifferE (1975) A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc23, 433–441.
38.
ParmeleePA, ThurasPD, KatzIR, LawtonMP (1995) Validation of the Cumulative illness rating scale in a geriatric residential population. J Am Geriatr Soc43, 130–137.
39.
VellasB, GuigozY, GarryPJ, NourhashemiF, BennahumD, LauqueS, AlbaredeJL (1999) The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition15, 116–122.
40.
BlissMR, McLarenR, Exton-SmithAN (1996) Mattresses for preventing pressure sores in geriatric patients. Mon Bull Minist Health Public Health Lab Serv25, 238–268.
41.
PilottoA, FerrucciL, FranceschiM, D’AmbrosioLP, ScarcelliC, CascavillaL, ParisF, PlacentinoG, SeripaD, DallapiccolaB, LeandroG (2008) Development and validation of a multidimensional prognostic index for 1-year mortality from the comprehensive geriatric assessment in hospitalized older patients. Rejuvenation Res11, 151–161.
42.
HamrinE, LindmarkB (1988) Evaluation of functional capacity after stroke as a basis for active intervention. Scand J Caring Sci2, 113–122.
43.
HudonC1, FortinM, VanasseA (2005) Cumulative Illness Rating Scale was a reliable and valid index in a family practice context. J Clin Epidemiol58, 603–608.
44.
HailemariamH, Pragya SinghP, FekaduT (2016) Evaluation of mini nutrition assessment (MNA) tool among community dwelling elderly in urban community of Hawassa city, Southern Ethiopia. BMC Nutr2, 11.
45.
Pancorbo-HidalgoPL1, Garcia-FernandezFP, Lopez-MedinaIM, Alvarez-NietoC (2006) Risk assessment scales for pressure ulcer prevention: A systematic review. J Adv Nurs54, 94–110.
46.
CronbachLJ (1951) Coefficient alpha and the internal structure of test. Psychometrika16, 297–334.
47.
BomboisS, DebetteS, DelbeuckX, BruandetA, LepoittevinS, DelmaireC (2007) Prevalence of subcortical vascular lesions and association with executive function in mild cognitive impairment subtypes. Stroke38, 2595–2597.
48.
RosenbergPB, MielkeMM, ApplebyB, OhE, LeoutsakosJM, LyketsosCG (2011) Neuropsychiatric symptoms in MCI subtypes: The importance of executive dysfunction. Int J Geriatr Psychiatry26, 364–372.
49.
KalariaRN (2003) Comparison between Alzheimer’s disease and vascular dementia: Implications for treatment. Neurol Res25, 661–664.
50.
de la TorreJC (2004) Is Alzheimer’s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol3, 184–190.
51.
Gunning-DixonFM, RazN (2003) Neuroanatomical correlates of selected executive functions in middle-aged and older adults: A prospective MRI study. Neuropsychologia41, 1929–1941.
52.
YoonCW, ShinJS, KimHJ, ChoH, NohY, KimGH, ChinJH, OhSJ, KimJS, ChoeYS, LeeKH, LeeJH, SeoSW, NaDL (2013) Cognitive deficits of pure subcortical vascular dementia vs. Alzheimer disease: PiB-PET-based study. Neurology80, 569–573.
SmitsLL, van HartenAC, PijnenburgYA, KoedamEL, BouwmanFH, SistermansN, ReulingIE, PrinsND, LemstraAW, ScheltensP, van derFlier WM (2015) Trajectories of cognitive decline in different types of dementia. Psychol Med45, 1051–1059.
55.
LooiJC, SachdevPS (1999) Differentiation of vascular dementia from AD on neuropsychological tests. Neurology53, 670–670.
56.
HashimotoM, KitagakiH, ImamuraT, HironoN, ShimomuraT, KazuiH, TanimukaiS, HaniharaT, MoriE (1998) Medial temporal and whole-brain atrophy in dementia with Lewy bodies: A volumetric MRI study. Neurology51, 357–362.
57.
BarberR, ScheltensP, GholkarA, BallardC, McKeithI, InceP, PerryR, O’BrienJ (1999) White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry67, 66–72.
58.
BarberR, GholkarA, ScheltensP, BallardC, McKeithIG, O’BrienJT (2000) MRI volumetric correlates of white matter lesions in dementia with Lewy bodies and Alzheimer’s disease. Int J Geriatr Psychiatry15, 911–916.
